Trial Profile
Basiliximab and infliximab combination treatment in patients with severe gastrointestinal acute graft-versus-host disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2015
Price :
$35
*
At a glance
- Drugs Basiliximab (Primary) ; Infliximab (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 04 Nov 2015 New trial record
- 19 Oct 2015 Results published in Bone Marrow Transplantation.